Ohio State Navbar

OSU Study: Drop Popular Asthma Treatment

Ohio State University researchers say a study indicating a common asthma treatment shows no benefit could actually be a good thing for health care. The university’s Dr. John Mastronarde was chief investigator for the 20-hospital study that followed 402 patients for 24 weeks to determine if medication that reduces stomach acid, usually used to treat heartburn caused by acid reflux, would reduce asthma symptoms. It did not. “This research is especially important because, by determining which patients do not need the additional medication, we are saving them unnecessary costs, potential side effects and the risk of interactions with other drugs,” said Mastronarde, a specialist in lung function and critical care at OSU Medical Center.

For more on this story click here